The Europe immunochemistry market is expected to reach US$ 775.97 Mn in 2027 from US$ 430.82 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.
The growth of the market is driven by the factors such as, significantly increasing prevalence of cardiovascular diseases and rising incidence of diabetes. However, the market is likely to slower down its growth due to the shortage of skilled professionals.
The healthcare industry has been observing rapid transformations during the previous years. Various technological improvements have been witnessed in the segments such as, diagnosis and treatment options for chronic diseases. The increase in incidences of chronic illnesses, ageing population, are the primary factors fuelling the growth of healthcare segment.
Germany has a history of manufacturing high diagnostic imaging technologies, precision medical instruments and others. There has been an increase in the healthcare expenditure in the European countries during the previous years. As per Eurostat in 2016, healthcare expenditure in Germany was EUR 352 billion. Medical technologies is the priority of Healthcare/Life Sciences (HCT) industry. Whereas the healthcare expenditure of France was recorded as the second highest which was around EUR 257 billion, followed by the United Kingdom EUR 234 billion.
The above mentioned factors are expected to offer broad growth opportunities in the healthcare industry and this is expected to cause the demand for immunochemistry assays in the market.
Germany is expected to lead the market in the Europe region owing to the factors such as an increase in the number of cancer cases, the higher prevalence of the diseases, government initiatives, and investments for the research and development by the government bodies and private entities. Along with the government, private companies are also focusing on the development of the conditions in the country. Therefore, considering the above-mentioned factors the growth of the market in the country is likely to contribute the largest share in the Europe region during the forecast period.
EUROPE IMMUNOHISTOCHEMISTRY – MARKET SEGMENTATION
By Product
By Application
By End User
By Geography
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 430.82 Million |
| Market Size by 2027 | US$ 775.97 Million |
| CAGR (2019 - 2027) | 6.9% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Application
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
The Europe Immunochemistry Market is valued at US$ 430.82 Million in 2018, it is projected to reach US$ 775.97 Million by 2027.
As per our report Europe Immunochemistry Market, the market size is valued at US$ 430.82 Million in 2018, projecting it to reach US$ 775.97 Million by 2027. This translates to a CAGR of approximately 6.9% during the forecast period.
The Europe Immunochemistry Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Immunochemistry Market report:
The Europe Immunochemistry Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Immunochemistry Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Immunochemistry Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Europe Immunochemistry Market
